These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 4765762)

  • 21. Radiopaque contrast media. XXV. Physicochemical properties of iodoxamic acid, a new intravenous cholecystographic agent.
    Felder E; Pitré D; Grandi M
    Farmaco Sci; 1973 Nov; 28(11):925-36. PubMed ID: 4762845
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative study of the binding to human serum albumin of biliscopine (a new cholangiographic contrast medium) and five other contrast media.
    Mathieu J; Looze Y; Deconinck M
    Rofo; 1979 Apr; 130(4):418-20. PubMed ID: 155594
    [No Abstract]   [Full Text] [Related]  

  • 23. [New intravenously applied biliary contrast medium].
    Cassebaum H; Dierbach K; Bekker H
    Pharmazie; 1967 Sep; 22(9):470-4. PubMed ID: 5599141
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacology of iotroxic acid, a new intravenous cholangiographic agent. II. Experimental animal study of side effects].
    Speck U; Düsterberg B; Mannesmann G; Siefert HM
    Arzneimittelforschung; 1978; 28(12):2290-6. PubMed ID: 582945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The uricosuric action of contrast media used for the opacification of bile ducts (apropos of 27 cases)].
    Billis A; Dimopoulos C; Giamarellou H; Zoumbouli I; Papadimitriou A; Sagiorgis G; Kaniouras N; Scouteris M; Daïcos G
    Ann Med Interne (Paris); 1973 Dec; 124(12):853-62. PubMed ID: 4598722
    [No Abstract]   [Full Text] [Related]  

  • 26. The biliary and urinary excretion and the choleretic effect of ioglycamide in dogs.
    Loeb PM; Berk RN; Cobo-Frenkel A; Barnhart JL
    Invest Radiol; 1976 SEP-OCT; 11(5):449-58. PubMed ID: 989758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Animal experiments on the distribution and excretion of an intravenously injected biliary contrast medium (Ioglycomate) (author's transl)].
    Hilweg D
    Rofo; 1976 Apr; 124(4):320-7. PubMed ID: 131756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous cholangiography using ioglycamate (Biligram) infusion. A report on 150 cases.
    Cantwell DF
    Ir J Med Sci; 1974 Nov; 143(6):325-9. PubMed ID: 4436018
    [No Abstract]   [Full Text] [Related]  

  • 29. [The results and tolerability of infusion cholegraphy using ioglycamide-85 (12.75 g meglumine salt in 75 ml) in comparison with the use of a hypotonic adipiodone solution (10 g meglumine salt in 100 ml)].
    Ronneburg HP
    Radiol Diagn (Berl); 1990; 31(3):253-60. PubMed ID: 2367631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Infusion cholangiography from the physiological viewpoint].
    Miller G; Fuchs WA; Preisig R
    Schweiz Med Wochenschr; 1969 Apr; 99(16):577-81. PubMed ID: 5768015
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of the Y and Z hepatic proteins in the excretion of radiographic contrast materials.
    Sokoloff J; Berk RN; Lang JH; Lasser EC
    Radiology; 1973 Mar; 106(3):519-23. PubMed ID: 4684791
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of iopromide in rat and dog.
    Mützel W; Speck U; Weinmann HJ
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():85-90. PubMed ID: 6139085
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravenous cholegraphy by iotroxate preparation (Biliscopin) - comparison of iotroxate with iodoxamate.
    Konishi K; Ueno K; Sawa T; Miyazaki I
    Br J Radiol; 1982 Aug; 55(656):609-10. PubMed ID: 6896836
    [No Abstract]   [Full Text] [Related]  

  • 34. [Problems related to the radiographic study of the biliary tract using oral or intravenous contrast media. Main side effects and biochemical changes induced by the administration of contrast media].
    Limido G
    Minerva Dietol Gastroenterol; 1984; 30(1):9-15. PubMed ID: 6374500
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacologic properties of various iodinated N-aryldicarbonic acid monoamides].
    Bekker H; Cassebaum H; Lietz W
    Pharmazie; 1972 Jun; 27(6):411-4. PubMed ID: 5082268
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prospects of using modern x-ray contrast substances for intravenous cholegraphy (a review of the literature)].
    Sviridov NK
    Vestn Rentgenol Radiol; 1981; (6):78-81. PubMed ID: 7036516
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of metrizamide on the sedimentation rate of red blood cells.
    Almén T
    Acta Radiol Suppl; 1973; 335():229-32. PubMed ID: 4534558
    [No Abstract]   [Full Text] [Related]  

  • 38. Biliary iodipamide and iodoxamate excretion as function of basal bile flow in normal, common bile duct obstructed and liver-damaged dogs.
    Burgener FA
    Rofo; 1981 Jan; 134(1):40-3. PubMed ID: 6452332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Significance of the liver cell in elimination of cholegraphic agents (author's transl)].
    Otto H
    Radiologe; 1980 Jan; 20(1):16-23. PubMed ID: 7360933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagon in intravenous cholangiography--an experimental study on dogs.
    Tötterman S; Santavirta S; Antila H
    Rofo; 1980 Apr; 132(4):454-6. PubMed ID: 6450110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.